Last update:
Urology news
Should lowest-risk prostate 'cancer' still be called cancer? How changing the name could save lives
A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could dramatically reduce overtreatment ...
7 hours ago
0
1
DNA methylation patterns may explain why some prostate cancers turn lethal
The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million American men, with another 330,000 men expected to be diagnosed with the condition this year alone.
15 hours ago
0
3
Next-generation HIF-2α inhibitor shows promise in kidney cancer translational clinical trial
The first-in-patient, single-arm ARC-20 clinical trial, led by Dana-Farber Cancer Institute's Toni K. Choueiri, MD, has evaluated casdatifan, a next-generation HIF-2α inhibitor, as monotherapy for metastatic clear cell renal ...
12 hours ago
0
2
Early benign prostatic hyperplasia outcomes comparable for p-ThuLEP and open prostatectomy
For patients with benign prostatic hyperplasia (BPH), early functional outcomes are comparable with high-peak-power pulsed Thulium:YAG laser enucleation (p-ThuLEP) and open simple prostatectomy (OSP), but shorter hospitalization ...
Jun 30, 2026
0
3
Low grip strength should not be used as an independent predictor of prostate cancer in older men
New research suggests that low handgrip strength alone is not a reliable predictor of increased prostate cancer risk among older men. The relationship between low handgrip strength (HGS) and prostate cancer has long remained ...
Jun 29, 2026
0
3
Intravesical CAR T therapy opens door to bladder-sparing cancer treatment
Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill bladder cancer cells. The ...
Jun 26, 2026
0
5
What happens when celebrities talk about their prostate cancer?
When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media coverage raises awareness. More men may seek information or medical advice.
Jun 26, 2026
0
4
Developing a new methodology to identify biomarkers for male infertility
Researchers from the EHU-University of the Basque Country have developed a robust protocol to detect the molecules involved in the metabolic reactions of sperm. The new method enables a detailed analysis even with small samples ...
Jun 25, 2026
0
3
Significant association identified between hepatitis C, overactive bladder
There is a significant association between hepatitis C virus (HCV) and overactive bladder (OAB), according to a study published online May 29 in BMC Urology.
Jun 25, 2026
0
3
Targeting cannabinoid receptors in bladder sensory pathways may alleviate pain of cystitis
The burning pain associated with cystitis affects millions of people around the world, and it can take days or even years for some patients to find relief from bladder pain, infection-related symptoms and the constant need ...
Jun 25, 2026
0
3
Six-month results confirm feasibility and early success of first in-human combined bladder-kidney transplant
The first-in-human fully vascularized bladder graft transplanted with a kidney has reached a promising six-month milestone, according to a new feasibility study published in The Lancet. The procedure, performed in May 2025, ...
Jun 24, 2026
0
4
New blood test detects more high-risk prostate cancer cases
A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically significant cancer cases than the ...
Jun 23, 2026
0
8
FDA approves oral Utebzi antibiotic for complicated urinary tract infections
The U.S. Food and Drug Administration has approved GSK's Utebzi (tebipenem pivoxil), an oral antibiotic, for the treatment of complicated urinary tract infections (cUTIs).
Jun 23, 2026
0
4
Testosterone therapy labels and limits may change under FDA proposal
The U.S. Food and Drug Administration (FDA) is asking drugmakers to update the prescribing information on testosterone replacement therapy products to reflect newer clinical evidence.
Jun 23, 2026
0
4
FDA approves Welireg with pembrolizumab for renal cell carcinoma
The U.S. Food and Drug Administration has approved Merck's Welireg (belzutifan) in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the adjuvant treatment of renal cell carcinoma ...
Jun 19, 2026
0
8
Jeremy Clarkson has aggressive prostate cancer. What makes some cancers more aggressive than others?
UK media celebrity Jeremy Clarkson this week revealed he has been diagnosed with an aggressive form of prostate cancer.
Jun 18, 2026
0
15
Spatial map of bladder cancer reveals hidden tumor environments, new paths toward precision therapy
Researchers at The University of Texas MD Anderson Cancer Center have developed a spatial map of muscle-invasive bladder cancer, revealing how tumor cell states, immune environments and therapeutic vulnerabilities are organized ...
Jun 18, 2026
0
3
Hidden PIM1 pathway helps prostate cancer survive treatment, pointing to new drug strategy
Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, fueling drug resistance and disease progression.
Jun 16, 2026
0
7
Three men's health drugs that were originally designed for a different purpose
Many medicines begin life with one purpose and end up proving useful for a completely different reason.
Jun 16, 2026
0
4
Experimental treatment directly kills prostate tumor cells while reawakening antitumor immunity
Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing antitumor immunity, according to a preclinical study led by investigators at Weill Cornell ...
Jun 15, 2026
0
12
Clinical trials suggest GLP-1s may improve fertility in men with obesity
GLP-1s do not harm male hormones or fertility after long-term use, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago. In fact, the research team found GLP-1s may improve ...
Jun 15, 2026
0
5
FDA approves combination therapy for higher-risk clear cell kidney cancer after surgery
The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor, as adjuvant treatment for adult patients with renal cell carcinoma with a clear cell component ...
Jun 15, 2026
0
3
Hard-to-detect prostate cancer may grow through cancer-stroma KRAS signaling
A research team at Kanazawa University, led by Professor Atsushi Mizokami, Associate Professor Koji Izumi and Specially Appointed Assistant Professor Taiki Kamishima (a fourth-year doctoral student at the Graduate School ...
Jun 12, 2026
0
6
Immune biomarkers may predict response to bladder cancer treatment
A Northwestern Medicine study has offered new clues as to why immunotherapy works well for some bladder cancer patients but fails for others, according to a study published in the Journal of Clinical Investigation.
Jun 10, 2026
0
4
First report on the clinical efficacy of chemoimmunotherapy for ultra-rare urachal cancer
Physician-scientists at Kanazawa University have demonstrated, for the first time, the clinical efficacy of chemoimmunotherapy in patients with ultra-rare urachal cancer. Furthermore, their reverse translational research ...
Jun 10, 2026
0
3
